MindBio Therapeutics Corp. (CSE:MBIO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Jun 27, 2025, 4:00 PM EDT
-85.71%
Market Cap 2.84M
Revenue (ttm) -565.34K
Net Income (ttm) -1.46M
Shares Out 567.95M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 296,000
Average Volume 224,272
Open 0.0050
Previous Close 0.0100
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.0500
Beta 0.13
RSI 44.79
Earnings Date Oct 29, 2025

About MindBio Therapeutics

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated v... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MBIO
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements

News

There is no news available yet.